Orion Biotech Opportunities Corp. Warrant

Company Profile

Orion Biotech Opportunities Corp. Warrant had its IPO on 2021-07-07 under the ticker symbol ORIAW.

The company operates in the Financial Services sector and Shell Companies industry. Orion Biotech Opportunities Corp. Warrant has a staff strength of 0 employees.

Stock update

Shares of Orion Biotech Opportunities Corp. Warrant opened at $0 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0 - $0, and closed at $0.

This is a -88% slip from the previous day's closing price.

A total volume of 10,000 shares were traded at the close of the day’s session.

In the last one week, shares of Orion Biotech Opportunities Corp. Warrant have slipped by -81.54%.

Orion Biotech Opportunities Corp. Warrant's Key Ratios

Orion Biotech Opportunities Corp. Warrant has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Orion Biotech Opportunities Corp. Warrant’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures Orion Biotech Opportunities Corp. Warrant's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Orion Biotech Opportunities Corp. Warrant’s operating margin was 0% while its return on assets stood at -0.28% with a return of equity of 0%.

In Q4, Orion Biotech Opportunities Corp. Warrant’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Orion Biotech Opportunities Corp. Warrant’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Orion Biotech Opportunities Corp. Warrant’s profitability.

Orion Biotech Opportunities Corp. Warrant stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Orion Biotech Opportunities Corp. Warrant stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$203.33 million

Total Liabilities

$67593.00

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Orion Biotech Opportunities Corp. Warrant ended 2023 with $203.33 million in total assets and $0 in total liabilities. Its intangible assets were valued at $203.33 million while shareholder equity stood at $195.00 million.

Orion Biotech Opportunities Corp. Warrant ended 2023 with $0 in deferred long-term liabilities, $67593.00 in other current liabilities, 202793965.00 in common stock, $-7792939.00 in retained earnings and $0 in goodwill. Its cash balance stood at $265717.00 and cash and short-term investments were $265717.00. The company’s total short-term debt was $0 while long-term debt stood at $0.

Orion Biotech Opportunities Corp. Warrant’s total current assets stands at $439320.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $7718.00 and inventory worth $0.

In 2023, Orion Biotech Opportunities Corp. Warrant's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Orion Biotech Opportunities Corp. Warrant paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$0

52-Week High

$0.6004

52-Week Low

$0.0011

Analyst Target Price

$

Orion Biotech Opportunities Corp. Warrant stock is currently trading at $0 per share. It touched a 52-week high of $0.6004 and a 52-week low of $0.6004. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.11 and 200-day moving average was $0.2 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.